Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading global non-profit organization dedicated to funding innovative research to discover cures and more effective treatments for neuroendocrine tumors (NETs). Since its founding in 2005, the foundation has awarded over $30 million in research grants to leading scientists at premier academic institutions worldwide. NETRF focuses on high-impact projects ranging from basic laboratory science to translational research and early-stage clinical trials. In addition to its robust research portfolio, the foundation provides essential educational resources and support for patients, caregivers, and healthcare professionals. By fostering international collaboration and scientific discovery, NETRF plays a pivotal role in advancing the standard of care for patients with these rare cancers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuroendocrine Research Foundation.